Enovis (ENOV) EPS (Basic) Growth (3y) (2013 - 2026)
Analysis
Enovis (ENOV) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.55 Bn | 175.95 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.18 Bn | 108.37 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 105.17 Bn | 101.69 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 64.67 Bn | 64.13 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 17.98% |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 53.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 53.60% |
| Apr 3, 2026 | 29.81% |
| Dec 31, 2025 | -133.82% |
| Oct 3, 2025 | -101.10% |
| Jul 4, 2025 | -34.80% |
| Apr 4, 2025 | -76.59% |
| Dec 31, 2024 | -945.04% |
| Sep 27, 2024 | -46.62% |
| Jun 28, 2024 | -37.58% |
| Mar 29, 2024 | -73.30% |
| Dec 31, 2023 | 26.51% |
| Sep 29, 2023 | -29.61% |
| Jun 30, 2023 | 1.06% |
| Mar 31, 2023 | -85.00% |
| Dec 31, 2022 | -28.16% |
| Sep 30, 2022 | -94.16% |
| Jul 1, 2022 | 28.82% |
| Apr 1, 2022 | 30.84% |
| Dec 31, 2021 | -26.19% |
| Oct 1, 2021 | -18.39% |